Literature DB >> 22223211

Autoantibodies in heart failure and cardiac dysfunction.

Ziya Kaya1, Christoph Leib, Hugo A Katus.   

Abstract

Human heart failure is a disease with multifactorial causes, considerable morbidity, and high mortality. Several circulating autoantibodies, some of them being heart-specific, play a crucial role in the progression and induction of heart failure. However the precise mechanisms on how these autoantibodies perpetuate or even induce an organ specific autoimmune response are not yet fully understood. Also it is being a matter of current research to elucidate a potential pathophysiological role of the innate immune system in generating auto-reactive antibodies. In this review we will summarize the current available literature on circulating autoantibodies which are related to human heart failure. We will present clinical and animal studies that demonstrate the occurrence and pathophysiological relevance of several autoantibodies in heart failure, as well as point out biological mechanisms on molecular and cellular level. Finally the beneficial therapeutic effects of numerous clinical studies that target the humoral arm of the immune system by using either intravenous immunoglobulins and/or immunoadsorption will be critically discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22223211     DOI: 10.1161/CIRCRESAHA.111.243360

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  59 in total

1.  Localization of CD8 T cell epitope within cardiac myosin heavy chain-α334-352 that induces autoimmune myocarditis in A/J mice.

Authors:  Chandirasegaran Massilamany; Arunakumar Gangaplara; Rakesh H Basavalingappa; Rajkumar A Rajasekaran; Vahid Khalilzad-Sharghi; Zhongji Han; Shadi Othman; David Steffen; Jay Reddy
Journal:  Int J Cardiol       Date:  2015-09-18       Impact factor: 4.164

Review 2.  Innate immunity and the failing heart: the cytokine hypothesis revisited.

Authors:  Douglas L Mann
Journal:  Circ Res       Date:  2015-03-27       Impact factor: 17.367

3.  Peptide ligand-based ELISA reagents for antibody detection.

Authors:  Ewa Heyduk; Rachel Hickey; Nicola Pozzi; Tomasz Heyduk
Journal:  Anal Biochem       Date:  2018-08-18       Impact factor: 3.365

Review 4.  Mechanisms of Autoantibody-Induced Pathology.

Authors:  Ralf J Ludwig; Karen Vanhoorelbeke; Frank Leypoldt; Ziya Kaya; Katja Bieber; Sandra M McLachlan; Lars Komorowski; Jie Luo; Otavio Cabral-Marques; Christoph M Hammers; Jon M Lindstrom; Peter Lamprecht; Andrea Fischer; Gabriela Riemekasten; Claudia Tersteeg; Peter Sondermann; Basil Rapoport; Klaus-Peter Wandinger; Christian Probst; Asmaa El Beidaq; Enno Schmidt; Alan Verkman; Rudolf A Manz; Falk Nimmerjahn
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 5.  Immune Modulation in Heart Failure: the Promise of Novel Biologics.

Authors:  Paulino Alvarez; Alexandros Briasoulis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-15

Review 6.  Reappraising the role of inflammation in heart failure.

Authors:  Luigi Adamo; Cibele Rocha-Resende; Sumanth D Prabhu; Douglas L Mann
Journal:  Nat Rev Cardiol       Date:  2020-01-22       Impact factor: 32.419

7.  Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of CVB3 infection.

Authors:  Rakesh H Basavalingappa; Rajkumar Arumugam; Ninaad Lasrado; Bharathi Yalaka; Chandirasegaran Massilamany; Arunakumar Gangaplara; Jean-Jack Riethoven; Shi-Hua Xiang; David Steffen; Jay Reddy
Journal:  Mol Immunol       Date:  2020-06-29       Impact factor: 4.407

Review 8.  Anti-cardiac troponin antibodies in clinical human disease: a systematic review.

Authors:  Eduardo M Vilela; Rita Bettencourt-Silva; J Torres da Costa; Ana Raquel Barbosa; Marisa P Silva; Madalena Teixeira; João Primo; Vasco Gama Ribeiro; José Pedro L Nunes
Journal:  Ann Transl Med       Date:  2017-08

Review 9.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

10.  Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling.

Authors:  Ding-Sheng Jiang; Xiao-Fei Zhang; Lu Gao; Jing Zong; Heng Zhou; Yu Liu; Yan Zhang; Zhou-Yan Bian; Li-Hua Zhu; Guo-Chang Fan; Xiao-Dong Zhang; Hongliang Li
Journal:  Hypertension       Date:  2013-10-07       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.